Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40Â KD)/ribavirin

Early, sustained suppression of HCV replication portends an SVR. Cessation of treatment may be contemplated in patients without a ≥2 log10 reduction in HCV RNA after 12 weeks.